Adam Sidaway

Adam Sidaway is a Lead Scientist at Uncommon, with previous experience as a Senior Scientist at Mogrify, Intima Bioscience, Bit Bio, and Adaptimmune. Adam has a PhD in Biochemistry from the University of Bristol. Adam specializes in CRISPR gene editing, iPSCs, immunology, and generation of blood cell types from stem cells. Adam was a founding lab member of the stem cell lab at Adaptimmune, contributing to the development of an off the shelf T-cell product derived from stem cells.